You are using a browser that is either out of date or not supported.
HIBM.ORG is best viewed using Firefox, Safari, Opera, or IE 6+.
Thank you for your attention.

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
research:research [2008/03/13 05:47] – danielresearch:research [2014/05/04 17:38] (current) – external edit 127.0.0.1
Line 3: Line 3:
 HIBM is caused by problems on an enzyme known as [[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603824 | GNE]].  Developing therapies for enzyme related muscle diseases have been historically less difficult that muscle wasting diseases caused by large structural proteins.  Thus, we are hopeful that therapy can be developed in the near future. HIBM is caused by problems on an enzyme known as [[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603824 | GNE]].  Developing therapies for enzyme related muscle diseases have been historically less difficult that muscle wasting diseases caused by large structural proteins.  Thus, we are hopeful that therapy can be developed in the near future.
  
-To learn more about how therapies are developed, you may visit [[http://hibm.org/hrg/pages/welcome/developing-rx.php | HRG website, developing therapy]], and [[http://hibm.org/hrg/pages/welcome/research-articles.php | research articles]]+To learn more about how therapies are developed, you may visit [[http://www.hibm.org/hrg/hrgwww/fordoctors:developing_therapy | HRG website, developing therapy]], and [[http://www.hibm.org/hrg/hrgwww/fordoctors:research_articles | research articles]].